Cardiovascular events in cancer patients with bone metastases-A Danish population-based cohort study of 23,113 patients
- PMID: 34076356
- PMCID: PMC8290242
- DOI: 10.1002/cam4.4027
Cardiovascular events in cancer patients with bone metastases-A Danish population-based cohort study of 23,113 patients
Abstract
Introduction: The incidence of cardiovascular events among cancer patients with bone metastases is poorly understood. We examined rates of cardiovascular events among cancer patients with bone metastases and mortality following such events.
Methods: Using Danish health registries, we identified all Danish cancer patients diagnosed with bone metastases (1994-2013) and followed them from bone metastasis diagnosis. We computed incidence rates (IR) per 100 person-years and cumulative incidence for first-time inpatient hospitalization or outpatient clinic visit for cardiovascular events, defined as myocardial infarction, ischemic stroke, or venous thromboembolism (VTE). We also analyzed all-cause mortality rates including cardiovascular events as time-varying exposure with adjustment for age, sex, and Charlson Comorbidity Index score. All analyses were performed overall and stratified by cancer type (prostate, breast, lung, and other).
Results: We included 23,113 cancer patients with bone metastases. The cumulative incidence of cardiovascular events was 1.3% at 30 days, 3.7% at 1 year, and 5.2% at 5 years of follow-up. The highest IR was observed for VTE, followed by ischemic stroke and myocardial infarction, both overall and by cancer types. Lung cancer patients with bone metastases had the highest incidence of cardiovascular events followed by prostate and breast cancer. Occurrence of any cardiovascular event was a strong predictor of death (5 years following the event, the adjusted hazard ratio was 1.8 [95% confidence interval: 1.7-1.9]).
Conclusion: Cancer patients with bone metastases had a substantial risk of developing cardiovascular events, and these events were associated with a subsequent increased mortality. Our findings underscore the importance of continuous optimized prevention of and care for cardiovascular disease among cancer patients with bone metastases.
Keywords: bone metastasis; cancer; cardiovascular events; cohort; mortality; myocardial infarction; stroke; venous thromboembolism.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
AS and RH are employees of and own shares in Amgen. TR, HTS, AP, PA, KA, and JS have no personal conflict of interest.
Figures
Similar articles
-
Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.Circulation. 2014 Feb 25;129(8):855-63. doi: 10.1161/CIRCULATIONAHA.113.004168. Epub 2013 Nov 22. Circulation. 2014. PMID: 24270266
-
Survival after bone metastasis by primary cancer type: a Danish population-based cohort study.BMJ Open. 2017 Sep 11;7(9):e016022. doi: 10.1136/bmjopen-2017-016022. BMJ Open. 2017. PMID: 28893744 Free PMC article.
-
Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.Lung Cancer. 2014 Nov;86(2):247-54. doi: 10.1016/j.lungcan.2014.08.022. Epub 2014 Sep 10. Lung Cancer. 2014. PMID: 25240518
-
Depression, stroke, and dementia in patients with myocardial infarction.Dan Med J. 2018 Apr;65(4):B5423. Dan Med J. 2018. PMID: 29619929 Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Study on the knowledge, attitude and practice of single photon emission computed tomography among oncology healthcare professionals.Front Public Health. 2024 Dec 20;12:1512686. doi: 10.3389/fpubh.2024.1512686. eCollection 2024. Front Public Health. 2024. PMID: 39758198 Free PMC article.
-
The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis.Cancers (Basel). 2023 Sep 20;15(18):4640. doi: 10.3390/cancers15184640. Cancers (Basel). 2023. PMID: 37760609 Free PMC article. Review.
-
Oral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation.Cancer Sci. 2024 Feb;115(2):648-659. doi: 10.1111/cas.16010. Epub 2023 Dec 14. Cancer Sci. 2024. PMID: 38096871 Free PMC article.
-
Why do patients with cancer die?Nat Rev Cancer. 2024 Aug;24(8):578-589. doi: 10.1038/s41568-024-00708-4. Epub 2024 Jun 19. Nat Rev Cancer. 2024. PMID: 38898221 Free PMC article. Review.
-
Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.Cancers (Basel). 2022 Nov 22;14(23):5727. doi: 10.3390/cancers14235727. Cancers (Basel). 2022. PMID: 36497209 Free PMC article. Review.
References
-
- Yong M, Jensen AØ, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. Survival in breast cancer patients with bone metastases and skeletal‐related events: a population‐based cohort study in Denmark (1999–2007). Breast Cancer Res Treat. 2011;129(2):495‐503. - PubMed
-
- Nørgaard M, Jensen AØ, Jacobsen JB, Cetin K, Fryzek JP, Sørensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010;184(1):162‐167. - PubMed
-
- Coleman RE. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clin Cancer Res. 2006;12(20):6243s–6249s. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7‐34. - PubMed
-
- Al Husaini H, Wheatley‐Price P, Clemons M, Shepherd FA. Prevention and management of bone metastases in lung cancer: a review. J Thorac Oncol. 2009;4(2):251‐259. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical